Literature DB >> 21443852

Mechanism and biological implications of the NO release of cis-[Ru(bpy)2L(NO)](n+) complexes: a key role of physiological thiols.

Francisco O N Silva1, Manuela C L Cândido, Alda K M Holanda, Izaura C N Diógenes, Eduardo H S Sousa, Luiz G F Lopes.   

Abstract

Nitric oxide (NO) has a critical role in several physiological and pathophysiological processes. In this paper, the reactions of the nitrosyl complexes of [Ru(bpy)(2)L(NO)](n+) type, where L = SO(3)(2-) and imidazole and bpy = 2,2'-bipiridine, with cysteine and glutathione were studied. The reactions with cysteine and glutathione occurred through the formation of two sequential intermediates, previously described elsewhere, [Ru(bpy)(2)L(NOSR)](n+) and [Ru(bpy)(2)L(NOSR)(2)] (SR = thiol) leading to the final products [Ru(bpy)(2)L(H(2)O)](n+) and free NO. The second order rate constant for the second step of this reaction was calculated for cysteine k(2)(SR(-))=(2.20±0.12)×10(9) M(-1) s(-1) and k(2(RSH))=(154±2) M(-1) s(-1) for L = SO(3)(2-) and k(2)(SR(-))=(1.30±0.23)×10(9) M(-1) s(-1) and k(2)(RSH)=(0.84±0.02) M(-1) s(-1) for L = imidazole; while for glutathione they were k(2)(SR(-))=(6.70±0.32)×10(8) M(-1) s(-1) and k(2)(RSH)=11.8±0.3 M(-1) s(-1) for L = SO(3)(2-) and k(2)(SR(-))=(2.50±0.36)×10(8) M(-1) s(-1) and k(2)(RSH)=0.32±0.01 M(-1) s(-1) for L = imidazole. In all reactions it was possible to detect the release of NO from the complexes, which it is remarkably distinct from other ruthenium metallocompounds described elsewhere with just N(2)O production. These results shine light on the possible key role of NO release mediated by physiological thiols in reaction with these metallonitrosyl ruthenium complexes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21443852     DOI: 10.1016/j.jinorgbio.2011.02.004

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  5 in total

1.  Preconditioning with a novel metallopharmaceutical NO donor in anesthetized rats subjected to brain ischemia/reperfusion.

Authors:  Marcio Wilker Soares Campelo; Reinaldo Barreto Oriá; Luiz Gonzaga de França Lopes; Gerly Anne de Castro Brito; Armenio Aguiar dos Santos; Raquel Cavalcante de Vasconcelos; Francisco Ordelei Nascimento da Silva; Beatrice Nuto Nobrega; Moisés Tolentino Bento-Silva; Paulo Roberto Leitão de Vasconcelos
Journal:  Neurochem Res       Date:  2011-12-10       Impact factor: 3.996

2.  A divergent mode of activation of a nitrosyl iron complex with unusual antiangiogenic activity.

Authors:  Edinilton Muniz Carvalho; Lisa A Ridnour; Florêncio Sousa Gouveia Júnior; Pedro Henrique Bezerra Cabral; Nilberto Robson Falcão do Nascimento; David A Wink; Douglas W Franco; Mayara Jane Campos de Medeiros; Daniel de Lima Pontes; Elisane Longhinotti; Tércio de Freitas Paulo; Vania Bernardes-Génisson; Remi Chauvin; Eduardo Henrique Silva Sousa; Luiz Gonzaga de França Lopes
Journal:  J Inorg Biochem       Date:  2020-06-20       Impact factor: 4.155

3.  Nitric oxide and Brazilian propolis combined accelerates tissue repair by modulating cell migration, cytokine production and collagen deposition in experimental leishmaniasis.

Authors:  Milena Menegazzo Miranda; Carolina Panis; Allan Henrique Depieri Cataneo; Suelen Santos da Silva; Natalia Yoshie Kawakami; Luiz Gonzaga de França Lopes; Alexandre Tadachi Morey; Lucy Megumi Yamauchi; Célia Guadalupe Tardelli de Jesus Andrade; Rubens Cecchini; Jean Jerley Nogueira da Silva; José Maurício Sforcin; Ivete Conchon-Costa; Wander Rogério Pavanelli
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

4.  The Ruthenium Nitrosyl Moiety in Clusters: Trinuclear Linear μ-Hydroxido Magnesium(II)-Diruthenium(II), μ3-Oxido Trinuclear Diiron(III)-Ruthenium(II), and Tetranuclear μ4-Oxido Trigallium(III)-Ruthenium(II) Complexes.

Authors:  Iryna Stepanenko; Pavlo Mizetskyi; Ewelina Orlowska; Lukáš Bučinský; Michal Zalibera; Barbora Vénosová; Martin Clémancey; Geneviève Blondin; Peter Rapta; Ghenadie Novitchi; Wolfgang Schrader; Dominik Schaniel; Yu-Sheng Chen; Martin Lutz; Jozef Kožíšek; Joshua Telser; Vladimir B Arion
Journal:  Inorg Chem       Date:  2021-12-28       Impact factor: 5.165

5.  Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy.

Authors:  Eduardo Henrique Silva Sousa; Lisa A Ridnour; Florêncio S Gouveia; Carlos Daniel Silva da Silva; David A Wink; Luiz Gonzaga de França Lopes; Peter J Sadler
Journal:  ACS Chem Biol       Date:  2016-05-31       Impact factor: 5.100

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.